Wednesday, June 10, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1242 of 1,261
  1. US 6140339

    Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Oct 31, 2000 Β· Expires Oct 26, 2020

    expired
  2. US 6140068

    Protease resistant compositions for wound healing

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Oct 31, 2000 Β· Expires Oct 26, 2020

    expired
  3. US 6140122

    Process for preparing macrophages, kits, and compositions for the use of this process

    I.D.M. Immuno-Designed Molecules Β· Granted Oct 31, 2000 Β· Expires Oct 26, 2020

    expired
  4. US 6140083

    Leptospiral outer membrane protein, LipL46

    The Regents of the University of California Β· Granted Oct 31, 2000 Β· Expires Oct 26, 2020

    expired
  5. US 6136539

    Compositions and methods for the inhibition of MUC-5 mucin gene expression

    The Regents of the University of California Β· Granted Oct 24, 2000 Β· Expires Oct 19, 2020

    expired
  6. US 6136787

    Interleukin 1.beta. protease and interleukin 1.beta. protease inhibitors

    Vertex Pharmaceuticals Incorporated Β· Granted Oct 24, 2000 Β· Expires Oct 19, 2020

    expired
  7. US 6136306

    Method for treating tumors

    The Regents of the University of California Β· Granted Oct 24, 2000 Β· Expires Oct 19, 2020

    expired
  8. US 6136307

    Reovirus for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. Β· Granted Oct 24, 2000 Β· Expires Oct 19, 2020

    expired
  9. US 6136532

    Methods for treating bipolar mood disorder associated with markers on chromosome 18q

    The Regents of the University of California Β· Granted Oct 24, 2000 Β· Expires Oct 19, 2020

    expired
  10. US 6136781

    LH-RH receptor antagonists

    Takeda Chemical Industries Ltd. Β· Granted Oct 24, 2000 Β· Expires Oct 19, 2020

    expired
  11. US 6133278

    Use of quinone and hydroquinone derivatives for the treatment of cachexia

    Takeda Chemical Industries Ltd. Β· Granted Oct 17, 2000 Β· Expires Oct 12, 2020

    expired
  12. US 6133440

    Process for the preparation of immunomodulatory polysaccharides from aloe

    Univera Pharmaceuticals, Inc. Β· Granted Oct 17, 2000 Β· Expires Oct 12, 2020

    expired
  13. US 6133295

    Pharmaceutical composition

    Takeda Chemical Industries Ltd. Β· Granted Oct 17, 2000 Β· Expires Oct 12, 2020

    expired
  14. US 6133293

    Pharmaceutical composition

    Takeda Chemical Industries Ltd. Β· Granted Oct 17, 2000 Β· Expires Oct 12, 2020

    expired
  15. US 6132987

    Recombinant mammalian monocyte chemotactic protein-1 (MCP-1) receptors (MCP-1R, CCR-2)

    The Regents of the University of California Β· Granted Oct 17, 2000 Β· Expires Oct 12, 2020

    expired
  16. US 6133424

    ppRB.sup.110 - nuclear phosphoprotein-the retinoblastoma susceptibility gene product

    The Regents of the University of California Β· Granted Oct 17, 2000 Β· Expires Oct 12, 2020

    expired
  17. US 6133232

    Endoderm, cardiac and neural inducing factors

    The Regents of the University of California Β· Granted Oct 17, 2000 Β· Expires Oct 12, 2020

    expired
  18. US 6132962

    Retroviral vectors comprising an anti-hiv or other nucleic acid

    The Regents of the University of California Β· Granted Oct 17, 2000 Β· Expires Oct 12, 2020

    expired
  19. US 6132732

    Parvovirus capsids

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Oct 17, 2000 Β· Expires Oct 12, 2020

    expired
  20. US 6132724

    Allelic polygene diagnosis of reward deficiency syndrome and treatment

    The University of Texas System AMD Board of Regents Β· Granted Oct 17, 2000 Β· Expires Oct 12, 2020

    expired
  21. US 6132715

    Method of inhibiting biosynthesis of tumor necrosis factor

    Nika Health Products Limited Β· Granted Oct 17, 2000 Β· Expires Oct 12, 2020

    expired
  22. US 6133256

    Selective factor Xa inhibitors

    COR Therapeutics, Inc. Β· Granted Oct 17, 2000 Β· Expires Oct 12, 2020

    expired
  23. US 6133320

    Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors

    The Board of Regents of the University of Texas System Β· Granted Oct 17, 2000 Β· Expires Oct 12, 2020

    expired
  24. US 6133324

    Use of perillyl alcohol in organ transplantation

    The Regents of the University of California Β· Granted Oct 17, 2000 Β· Expires Oct 12, 2020

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.